OpenAI acquires biotech software startup Orchestra Bio
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
OpenAI acquired four-year-old Orchestra Bio for undisclosed terms, adding its team and AI agents for drug-discovery operations to the Rosalind model and Rosalind Workbench. The startup had reportedly raised about $20 million; Rosalind customers include Moderna and Novo Nordisk.
Continue in the app — vote & join in ➔Source: TechCrunch · via ahirlevel.hu